Abstract
Proteins are functional molecules in cells and are the major targets for drug action. To design a rational drug, we must firstly find out which proteins can be the drug targets in pathogenesis. Proteomics has great promise in identification of protein targets and biochemical pathways involved in disease processes. Proteomics as a whole increasingly plays an important role in the multi-step drug-development process. The process includes target identification and validation, lead selection, small-molecular screening and optimization, and toxicity testing. Furthermore, sub-disciplines such as computational proteomics, chemical proteomics, structural proteomics and topological proteomics offer significant contributions especially in computer-aided drug design. This review will summarize the recent progress in pharmaco-proteomics and the disciplines potential application in computer-assisted drug design.
Keywords: proteomics, drug design, drug target, protein target, target identification, lead validation, computer-aided drug design, protein profiling
Current Computer-Aided Drug Design
Title: Proteomics in Computer-Aided Drug Design
Volume: 1 Issue: 1
Author(s): Ying Wang, Jen-Fu Chiu and Qing-Yu He
Affiliation:
Keywords: proteomics, drug design, drug target, protein target, target identification, lead validation, computer-aided drug design, protein profiling
Abstract: Proteins are functional molecules in cells and are the major targets for drug action. To design a rational drug, we must firstly find out which proteins can be the drug targets in pathogenesis. Proteomics has great promise in identification of protein targets and biochemical pathways involved in disease processes. Proteomics as a whole increasingly plays an important role in the multi-step drug-development process. The process includes target identification and validation, lead selection, small-molecular screening and optimization, and toxicity testing. Furthermore, sub-disciplines such as computational proteomics, chemical proteomics, structural proteomics and topological proteomics offer significant contributions especially in computer-aided drug design. This review will summarize the recent progress in pharmaco-proteomics and the disciplines potential application in computer-assisted drug design.
Export Options
About this article
Cite this article as:
Wang Ying, Chiu Jen-Fu and He Qing-Yu, Proteomics in Computer-Aided Drug Design, Current Computer-Aided Drug Design 2005; 1 (1) . https://dx.doi.org/10.2174/1573409052952260
DOI https://dx.doi.org/10.2174/1573409052952260 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Studies on Anticancer Activities of Lactoferrin and Lactoferricin
Current Protein & Peptide Science Multifunctional Proteins in Tumorigenesis: Aminoacyl-tRNA Synthetases and Translational Components
Current Proteomics Applications of Ultrasound Elastography in Musculoskeletal Imaging: Technical Aspects and Review of the Literature
Current Medical Imaging Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy
Current Medicinal Chemistry Ribonucleases, Nucleases and Antiangiogenins in Antiproliferative Activities
Current Signal Transduction Therapy Targeting Platinum Resistant Disease in Ovarian Cancer
Current Medicinal Chemistry MicroRNAs Regulate the Epithelial to Mesenchymal Transition (EMT) in Cancer Progression
MicroRNA Management of Gene Variants of Unknown Significance: Analysis Method and Risk Assessment of the VHL Mutation p.P81S (c.241C>T)
Current Genomics Targeting SKCa Channels in Cancer: Potential New Therapeutic Approaches
Current Medicinal Chemistry A Review of the ADAMTS Family, Pharmaceutical Targets of the Future
Current Pharmaceutical Design PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies
Reviews on Recent Clinical Trials PET with Non-Standard Nuclides
Current Topics in Medicinal Chemistry The Role of Aromatase Enzyme in Hormone Related Diseases and Plant- Based Aromatase Inhibitors as Therapeutic Regimens
Current Topics in Medicinal Chemistry Angiogenic Properties of Primary Cells Intended at Bone Regeneration: A Comparison to Differentiated Cells Using the CAM Assay
Current Angiogenesis (Discontinued) Saccharomyces Cerevisiae as a Genetic Model in Anticancer Therapy
Current Pharmacogenomics The Interplay Between Inflammation and Oxidative Stress in Carcinogenesis
Current Molecular Medicine Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews Resisting the Resistance in Cancer: Cheminformatics Studies on Short- Path Base Excision Repair Pathway Antagonists Using Supervised Learning Approaches
Combinatorial Chemistry & High Throughput Screening Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Current Drug Targets Advanced Techniques for Penetration Enhancement in Transdermal Drug Delivery System
Current Drug Delivery